TF Securities(SH:601162) Zhong Guo Jing Ji Wang·2025-11-13 13:27Group 1 - He Yuan Bio, a star company innovating in "rice blood-making" technology, recently went public on the Shanghai Stock Exchange's Sci-Tech Innovation Board, with its market value increasing from 60 million to over 30 billion, a growth of over 500 times [1] - Tianfeng Securities has been a significant capital force for He Yuan Bio, accompanying the company for 15 years and participating in its angel round and Pre-IPO investments [3] - In 2023, Hubei Hongtai Group became the controlling shareholder of Tianfeng Securities, filling a gap in provincial state-owned capital controlling brokerages and enhancing local financial stability [3] Group 2 - Tianfeng Securities achieved a total operating income of 2.112 billion yuan from January to September 2023, a year-on-year increase of 57.53%, and net profit attributable to shareholders of the parent company was 153 million yuan, marking a turnaround from losses [3] - The total market value of Tianfeng Securities reached 59.23 billion yuan by the end of October 2023, an increase of 27.57 billion yuan since Hubei Hongtai Group took control in March 2023, moving from 16th to 5th in market value ranking among A-share listed companies in Hubei [3] - Tianfeng Securities has facilitated nearly 930 billion yuan in financing for the real economy over the past three years, including nearly 120 billion yuan for Hubei enterprises [4]